Reduced intake of deoxynivalenol in The Netherlands: a risk assessment update.

Toxicol Lett

National Institute of Public Health and the Environment, RIVM, Centre for Substances and Integrated Risk Assessment, P.O. Box 1, 3720 BA Bilthoven, The Netherlands.

Published: October 2004

In 1998 and 1999, wheat contained high levels of deoxynivalenol (DON) in The Netherlands. Eighty percent of the 1-year-old children exceeded the TDI (20% exceeded 2TDI). Assuming a long-term intake a negative effect on body weight might be possible. In 1999 the Dutch government took several risk management measures. We performed a probabilistic exposure and effect assessment and compared current and previous DON exposure and potential health effects for young children. The DON contamination of wheat was reduced for 50%. The estimated DON-intake was reduced to one-third of the previous levels. One-year-old children showed the highest DON-intake with a median of 0.46 microg/kgbw/day (95th percentile: 1.00 microg/kgbw/day). The probabilistic effect assessment showed that at the 95th percentile of DON-intake a reduced body weight was unlikely to exceed 9%. Taking into account the possible (partly) reversibility of this effect we conclude that no clear adverse health effects will be associated to the exposure (February 2000-December 2002) to DON in The Netherlands.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.toxlet.2004.04.029DOI Listing

Publication Analysis

Top Keywords

don netherlands
8
body weight
8
health effects
8
don-intake reduced
8
95th percentile
8
reduced
4
reduced intake
4
intake deoxynivalenol
4
deoxynivalenol netherlands
4
netherlands risk
4

Similar Publications

Purpose: In prostate cancer patients, high radiation doses to the urethra have been associated with an increased risk of severe genitourinary toxicity following dose-escalated radiotherapy. Urethra-sparing techniques have emerged as a promising approach to reduce urinary toxicity. This international survey aims to evaluate current global practices in urethra-sparing and explore future directions for the implementation of this technique in external beam radiotherapy (EBRT) for prostate cancer.

View Article and Find Full Text PDF

Novel species of fungi described in this study include those from various countries as follows: , from accumulated snow sediment sample. , on leaf spots of . , on submerged decaying wood in sea water, on , as endophyte from healthy leaves of .

View Article and Find Full Text PDF

« Augmented radiotherapy » in the management of high-risk prostate cancer (PCa): A systematic review.

Crit Rev Oncol Hematol

January 2025

Centre de Radiothérapie Charlebourg, La Défense, Groupe Amethyst, 65, avenue Foch, La Garenne-Colombes 92250, France; Department of radiation oncology, Institut Bergonié, Bordeaux, France.

Background: In patients with high-risk (HR) prostate cancer (PCa) treated with radiotherapy and androgen deprivation therapy (ADT), intensification with androgen receptor pathway inhibitor (ARPI) improves overall survival (OS), at the cost of significant side-effects. We hypothesized that "augmented RT" schedules (defined as either dose-escalation on the prostate gland over 78 Gy and/or addition of whole pelvic radiotherapy (WPRT)), combined with long-term ADT can reach excellent prostate cancer specific survival (PCSS) in this population with little detrimental impact on quality of life.

Methods: We searched Pubmed database until February 8, 2024.

View Article and Find Full Text PDF

Background: Around five billion people globally lack access to safe, timely, and affordable surgical facilities and care in low-income and middle-income countries (LMICs). Global initiatives have been launched, including efforts led by organizations. Also, regional efforts have shed light on the unique challenges faced by different areas within LMICs.

View Article and Find Full Text PDF

Background: The global burden of metabolic diseases is increasing, but estimates of their impact on primary liver cancer are uncertain. We aimed to assess the global burden of primary liver cancer attributable to metabolic risk factors, including high body mass index (BMI) and high fasting plasma glucose (FPG) levels, between 1990 and 2021.

Methods: The total number and age-standardized rates of deaths and disability-adjusted life years (DALYs) from primary liver cancer attributable to each metabolic risk factor were extracted from the Global Burden of Disease Study 1990-2021.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!